Ahmed Ossman
Tanta, El-Gharbia, 31527, Egypt
NCT Number: NCT05742503
The aim of this study is to assess the effect of different progesterone containing contraceptive methods on safety and endogenous progesterone level
Looking for future studies?
Notify Me20 year–35 year
Female
Observational
Tanta, El-Gharbia, 31527, Egypt
Progestogen-only' contraceptives are presented as injections, implants, oral formulations, hormone-releasing intrauterine methods and emergency contraceptives. These substances could be used by females who are breastfeeding or have other contraindications to estrogen treatment, including those who are immediately postpartum, have thalassemia, sickle-cell disease, gallbladder disease, or currently experiencing thrombo-embolic disorders, valvular heart disease, ischemic heart disease.
Intrauterine, injectable methods and contraceptive implants named as long-acting reversible contraceptives (LARC) are the more efficient reversible contraceptive approaches are highly effective, longer-acting contraceptive methods levels.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Injectable progesterone
Etonogestrel implant
Pill containing progesterone
Levonorgestrel-releasing intra-uterine drug (IUD)
Time frame: Six mounths
The effect of different progesterone containing contraceptive methods on safety and endogenous progesterone level will be recorded
Tanta University
Other
Effects of Different Progesterone Containing Contraceptive Methods on Safety and Endogenous Progesterone Level
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07173361
Female, Healthy Volunteers
Hamilton, Ontario, Canada
View Trial DetailsNCT05276531
Progesterone
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03734770
In Vitro Fertilization, Luteal Phase Support
Verona, Italy
View Trial DetailsNCT04769401
Genital Diseases, IVF
Istanbul, Turkey (Türkiye)
View Trial Details